Reva Medical (ASX:RVA) announced today that the company’s Fantom Encore bioresorbable vascular scaffold was used for the first time in Switzerland.
The sirolimus-eluting device, which is made from Reva’s proprietary Tyrocore polymer, features a 95-micron strut profile and x-ray visibility.
Get the full story at our sister site, Drug Delivery Business News.
The post Reva touts first implant of Fantom Encore bioresorbable scaffold in Switzerland appeared first on MassDevice.
from MassDevice https://ift.tt/2pMup80
Cap comentari:
Publica un comentari a l'entrada